MedTrace Logo

Study of Predictors of Failure of Sulprostone Treatment in Postpartum Hemorrhage

NCT06164236 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-12-27

No results posted yet for this study

Summary

The investigators wish to identify potential factors predicting failure of second-line drug treatment (sulproston (Nalador®)): risk factors and factors linked to a failure to take initial care for PPH.

A better understanding of the aggravating factors of HPP and more particularly the factors inherent to the initial care would make it possible to think of ways to improve practices.

Conditions

  • Postpartum Hemorrhage

Sponsors & Collaborators

  • University Hospital, Strasbourg, France

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-19
Primary Completion
2024-04-19
Completion
2024-04-19

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06164236 on ClinicalTrials.gov